Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7657
+0.0140 (1.86%)
At close: Sep 16, 2025, 4:00 PM EDT
0.7665
+0.0008 (0.10%)
Pre-market: Sep 17, 2025, 5:24 AM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $39.68 million as of September 17, 2025. Its market cap has increased by 12.36% in one year.
Market Cap
39.68M
Enterprise Value
-74.30M
1-Year Change
12.36%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $39.68M, a decrease of -90.70%. That is a compound annual growth rate of -45.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 39.68M | -9.11% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |